Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/57584
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAbhary, S.en
dc.contributor.authorBurdon, K.en
dc.contributor.authorGupta, A.en
dc.contributor.authorLake, S.en
dc.contributor.authorSelva-Nayagam, D.en
dc.contributor.authorPetrovsky, N.en
dc.contributor.authorCraig, J.en
dc.date.issued2009en
dc.identifier.citationInvestigative Ophthalmology & Visual Science, 2009; 50(12):5552-5558en
dc.identifier.issn0146-0404en
dc.identifier.issn1552-5783en
dc.identifier.urihttp://hdl.handle.net/2440/57584-
dc.description© 2009 by The Association for Research in Vision and Ophthalmology, Inc.en
dc.description.abstractPurpose. Vascular endothelial growth factor (VEGF) is a multifunctional cytokine that plays a role in angiogenesis and microvascular permeability. This study was conducted to determine whether common sequence variation in the VEGFA gene plays a role in the development of diabetic retinopathy (DR). Method. Five hundred fifty-four subjects with diabetes mellitus (DM) including 190 type 1 DM (T1DM) and 364 type 2 DM (T2DM) were recruited. The study group consisted of 235 participants without DR, 158 with nonproliferative DR (NPDR), 132 with proliferative DR (PDR), and 93 with clinically significant macular edema (CSME). Blinding DR was defined as severe NPDR, PDR, or CSME. Fifteen VEGFA tag single-nucleotide polymorphisms (SNPs) were genotyped in all subjects and tested for association with blinding DR. Results. Multiple tag SNPs in the VEGFA gene were associated with blinding DR. After controlling for sex, HbA1c, and duration of disease, in T1DM, the AA genotype of rs699946 (P = 0.007, odds ratio [OR], 4.1; 95% confidence interval [CI], 1.5–11.4) and the GG genotype of rs833068 (P = 0.017, OR, 3.1; 95% CI, 1.3–7.2) were most significantly associated. In T2DM, the C allele of rs3025021 (P = 0.002; OR, 3.8; 95% CI, 1.5–10.0) and the G allele of rs10434 (P = 0.002; OR, 2.6; 95% CI, 1.3–5.3) were most significantly associated with blinding DR. Haplotype analyses suggested an important role for the haplotype TCCGCG in blinding DR (P = 0.0004). Conclusions. Sequence variation in the VEGFA gene is associated with risk of developing blinding DR in T1DM and T2DM. Identifying specific genetic markers will allow for refined screening algorithms and earlier intervention in patients at highest risk.en
dc.description.statementofresponsibilitySotoodeh Abhary, Kathryn P. Burdon, Aanchal Gupta, Stewart Lake, Dinesh Selva, Nikolai Petrovsky and Jamie E. Craigen
dc.language.isoenen
dc.publisherAssoc Research Vision Ophthalmology Incen
dc.subjectHumans; Blindness; Diabetic Retinopathy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Vascular Endothelial Growth Factor A; Risk Factors; Genotype; Linkage Disequilibrium; Polymorphism, Single Nucleotide; Adult; Middle Aged; Female; Male; Glycated Hemoglobin Aen
dc.titleCommon sequence variation in the VEGFA gene predicts risk of diabetic retinopathyen
dc.typeJournal articleen
dc.identifier.rmid0020094089en
dc.identifier.doi10.1167/iovs.09-3694en
dc.identifier.pubid36552-
pubs.library.collectionOpthalmology & Visual Sciences publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidSelva-Nayagam, D. [0000-0002-2169-5417]en
Appears in Collections:Opthalmology & Visual Sciences publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.